cost to microdose glp 1 How Employers Can Manage GLP-1 Costs in Their Health Plans THE PCCA BLOG | Microdosing

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.

WhatsApp 922435001

The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeksin the phase one trial.

These drugs significantly reduced rates of #coloncancer (16% fewer cases) and #rectalcancer (28% fewer cases), among others like post-menopausal #breastcancer, #endometrialcancer, and #pancreaticcancer

Background: Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are synthetic peptides that mimic the natural activity of GLP-1, widely known for lowering blood glucose levels and promoting weight reduction

An accessible treatment to support your journey toward a healthier you.